Cytokinetics, Incorporated CYTK
$76.18
▲ +1.27% 24H
About
Cytokinetics, Incorporated is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors. These small-molecule therapies target debilitating diseases where muscle performance is compromised or declining, including a…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees673
TickerCYTK
Statistics
Market Cap$9.46B
Revenue (TTM)$88.0M
Net Income-$785.0M
Net Margin-891.6%
EPS$-6.54
P/E-10.59
P/S88.88
P/B-10.33
EV/EBITDA-14.26
ROE119.0%
Dividend Yield—
Price$76.18
Data: Twelve Data · Revenue = mcap / P/S